Filing Flows

Filing Flows › Zentalis Pharmaceuticals (ZNTL) › Next earnings date

Zentalis Pharmaceuticals (ZNTL) earnings on Nov 10, 2026: what to expect

Zentalis Pharmaceuticals (ZNTL) is expected to report earnings on Nov 10, 2026 (estimated), in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.52 (−$0.63 to −$0.42, 8 estimates), against −$0.37 a year ago. It beat the EPS estimate in 67% of the quarters on record; Filing Flows' model gives it a 74% chance of beating next time.

Report dateNov 10, 2026 (estimated)
Days to go2
EPS estimate−$0.52
Beat rate67%

The last report

Zentalis Pharmaceuticals reported revenue of $26.9M for the fourth quarter 2024, net loss $47.5M. How it makes money → · Every quarter →

Zentalis Pharmaceuticals: EPS against the estimate, last 3 reportsZentalis Pharmaceuticals: EPS against the estimate, last 3 reportsEstimateReported−$0.48−$0.37Nov 25−$0.61−$0.49Mar 26−$0.48−$0.59Aug 26
Latest (Aug 26): Estimate −$0.48, Reported −$0.59.

Zentalis Pharmaceuticals' latest quarter

Zentalis Pharmaceuticals, Q4 2024: revenue $26.9M, operating margin -185.6%, net loss $47.5M, operating cash flow −$39.7M. The chart follows the revenue to costs, profit and cash.

Questions

When does ZNTL report earnings?

Zentalis Pharmaceuticals is expected to report on Nov 10, 2026 (estimated).

What are analysts expecting from Zentalis Pharmaceuticals?

EPS of −$0.52 for the quarter.

Does Zentalis Pharmaceuticals usually beat earnings?

It beat the consensus EPS estimate in 67% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.